phenotyper automated home cages model 3000 (Noldus Information Technology)
Structured Review

Phenotyper Automated Home Cages Model 3000, supplied by Noldus Information Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phenotyper+automated+home+cages+model+3000/phenotyper+model+3000/pmc11911635-391-0-6
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "The behavioural consequences of dystrophinopathy"
Article Title: The behavioural consequences of dystrophinopathy
Journal: Disease Models & Mechanisms
doi: 10.1242/dmm.052047
Figure Legend Snippet: Serial reversal learning with food reward in PhenoTyper cages. Mdx 5cv ( n =9-10), mdx52 ( n =14), DMD-null ( n =10-15) and WT ( n =32-33). (A) Discrimination learning (left target). Both mdx 5cv and mdx52 mice showed steeper learning curves than those of WTs ( P< 0.001 and P= 0.011, respectively) and DMD-null mice ( P< 0.001 and P= 0.018, respectively). (B) Reversal day 1 (right target). Mdx 5cv mice showed decreased learning compared to WTs ( P =0.017). (C) Reversal day 2 (left target). Mdx52 mice showed increased performance compared to WTs and mdx 5cv mice ( P< 0.001 and P= 0.013, respectively). (D) Reversal day 3 (middle target). Mdx52 mice showed increased learning compared to WTs ( P= 0.018). (E) Reversal day 4 (right target). No differences were found between groups. (F) Reversal day 5 (left target). No differences were found between groups. All graphs were cut off at n= 3 for visual purposes. Cartoons were created in BioRender by Verhaeg, M. (2025). https://BioRender.com/e60i623 . This figure was sublicensed under CC-BY 4.0 terms.
Techniques Used:
Figure Legend Snippet: Spontaneous behavior in the PhenoTyper cages: activity-based behavior. Mdx 5cv ( n =14), mdx52 ( n =14), DMD-null ( n =16) and WT ( n =33). (A) Mdx52 mice showed a higher habituation index during the dark phase compared to WT, mdx 5cv and DMD-null mice ( P< 0.001, P= 0.025 and P <0.001, respectively). (B) Mean activity duration during the dark phase was lower in DMD-null mice than in WT and mdx 5cv mice ( P= 0.002 and P< 0.001, respectively). (C) In DMD-null mice, activity in anticipation of the dark phase was less changed than in WT mice ( P =0.004). (D) DMD-null mice showed less change in activity in response to the start of the dark phase than WTs ( P= 0.023). (E) Mdx52 mice showed a higher increase in activity in anticipation of the start of the light phase than WTs ( P= 0.032). (F) Mdx52 mice showed a lower decrease in activity change in response to the start of the light phase than WT and mdx 5cv mice ( P= 0.037 and P< 0.001, respectively). DMD-null mice also showed less of a decrease in activity than mdx 5cv mice ( P< 0.001). * P< 0.05, ** P< 0.01, *** P <0.001 (one-way ANOVA with post-hoc Tukey).
Techniques Used: Activity Assay
Figure Legend Snippet: Spontaneous behavior in the PhenoTyper cages: sheltering behavior, movement and arrest. Mdx 5cv ( n =14), mdx52 ( n =14), DMD-null ( n =16) and WT ( n =33). (A) The long shelter visit threshold was increased in mdx 5cv mice compared to that in WT and DMD-null mice ( P< 0.001 and P =0.007, respectively). (B) Both mdx52 and DMD-null mice showed a lower cumulative duration of shelter visits above the long shelter visit threshold compared to that in WTs ( P< 0.001 and P= 0.009, respectively). (C) The long movement threshold was lower in DMD-null mice than in WT, mdx 5v and mdx52 mice ( P< 0.001, P< 0.001 and P= 0.027, respectively). (D) DMD-null mice had a lower duration of arrests above the threshold than WT and mdx 5cv mice ( P= 0.014 and P= 0.009, respectively). * P< 0.05, ** P <0.01, *** P <0.001 (we refer the reader to for an overview of the statistical tests performed).
Techniques Used:
Related Articles
Activity Assay:Article Title: The behavioural consequences of dystrophinopathy Article Snippet: At 14 weeks of age, mice were housed in Article Title: The behavioural consequences of dystrophinopathy Article Snippet: |